Mobile Menu - OpenMobile Menu - Closed

Health Care



Brian has long said that health care needs a start, not a finish. With the passage of the 2009 Patient Protection and Affordable Care Act, our nation took a critical first step by giving millions of Americans access to health insurance, including those who had never had access before, like individuals with pre-existing conditions, and making sure that the high cost of medical treatments do not force families into bankruptcy. Brian supports efforts in Congress to come together across the aisle and improve the law, bringing down the cost curve and making the quality of care better for all Americans. 


More on Health Care

Feb 13, 2020 Press Release

Congressman Brian Higgins (NY-26) announced the House Committee on Ways and Means has approved the Consumer Protections Against Surprise Medical Bills Act (H.R. 5826).  The bipartisan legislation, cosponsored by Higgins, improves transparency and provides better protections for patients facing medical bills.

Feb 11, 2020 Press Release

Congressman Brian Higgins (NY-26), a member of the House of Representatives Budget Committee, provided in an analysis of the Trump Budget, released this week, the devastating impact it would have on the people, neighborhoods and economy of Western New York.

Jan 31, 2020 Press Release

Congressman Brian Higgins (NY-26) is pushing for approval of new legislation that would expand coverage, under Medicare, of the prescription drugs patients are required to take to reduce the risk of rejection following a kidney transplant.

Jan 22, 2020 Press Release

Congressman Brian Higgins (NY-26) announced that the Department of Housing and Urban Development’s (HUD) Continuum of Care (CoC) Program has awarded almost $12.3 million in federal funding to Western New York organizations to assist in their mission to end homelessness in the region.

Dec 13, 2019 Press Release

Congressman Brian Higgins (NY-26) announced House passage of H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, landmark legislation that reduces the cost of prescription drugs by empowering Medicare to negotiate the cost of drugs, caps out-of-pocket costs in Medicare Part D at $2,000, and requires drug companies to issue rebates if their costs rise faster than inflation.

Dec 10, 2019 Press Release

Congressman Brian Higgins (NY-26) testified before a House Energy and Commerce Health Subcommittee hearing, titled “Proposals to Achieve Universal Health Care Coverage,” in support of his bill H.R. 1346, the Medicare Buy-In and Health Care Stabilization Act. The bill, which is cosponsored by Representatives John Larson (CT-01), Joe Courtney (CT-02), and Peter Welch (VT-AL), allows those aged 50-64 to buy into the highly successful and popular Medicare program.

Oct 28, 2019 Press Release

Congressman Brian Higgins (NY-26) is calling for answers and action in response to nationwide pediatric cancer drug shortages that are resulting in the rationing of doses and in some cases delayed treatment for our youngest cancer warriors. 


Oct 24, 2019 Press Release

Congressman Brian Higgins (NY-26) participated in a markup hearing held by the House Ways and Means Committee which advanced five bills that lower the cost of prescription drugs, expand Medicare coverage for vision, dental, and hearing services, and create more opportunity and jobs in health care. Those bills are:

Oct 9, 2019 Press Release

WASHINGTON, DC – Today, Congresswoman Jan Schakowsky, a Senior Chief Deputy Whip and Chairwoman of the Consumer Protection and Commerce Subcommittee of the House Committee on Energy and Commerce, was joined by Representatives Brian Higgins (D-NY) and Susan Wild (D-PA) to introduce H.R. 4619, the Pharmaceutical Rebates for Excessive Pricing Above Inflation (REPAI) ActThis legislation will impose a new inflation rebate for the thousands of drugs that older Americans rely on and access through Medicare Part D.

Sep 27, 2019 Press Release

Congressman Brian Higgins (NY-26) spoke from the House floor to push for measures that would reduce the high cost of prescription drugs, including allowing the federal government to negotiate prescription drug prices.